M8474755
DolutegravirSRisomer , 95% , 1309560-49-3
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB10982.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 669.0±55.0 °C(Predicted) |
| Density | 1.53±0.1 g/cm3(Predicted) |
| pka | 4.50±1.00(Predicted) |
Description and Uses
Dolutegravir SR Isomer is an isomeric derivative of Dolutegravir (D528800), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. Dolutegravir SR Isomer.
RELATED PRODUCTS
![(4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide](https://img.chemicalbook.com/CAS/20150408/GIF/1335210-35-9.gif)
(4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
1335210-35-9
1335210-35-9
DolutegravirSodium
1051375-19-9
1051375-19-9
Dolutegravir Impurity 3
1973402-05-9
1973402-05-9
Dolutegravir (GSK1349572)
1051375-16-6
1051375-16-6
Dolutegravir 2-Desfluoro Impurity
1863916-88-4
1863916-88-4